Press release
Investigation announced for Investors in shares of GSK plc (NYSE: GSK) over possible Violations of Securities Laws
An investigation for investors in GSK plc (NYSE: GSK) shares over potential securities laws violations by GSK plc was announced.
Investors who purchased shares of GSK plc (NYSE: GSK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by GSK plc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
United Kingdom based GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.
On August 9, 2022, Vir Biotechnology, Inc. provided a corporate update and reported its second quarter 2022 financial results. Among other things, Vir Biotechnology, Inc., also stated that "Due to the evolving COVID-19 landscape and based on discussions with the US Food and Drug Administration (FDA), the Company and GSK do not plan to file a Biologics License Application for sotrovimab at this time and do not intend to pursue the US-based Phase 3 COMET-STAR prophylaxis trial. Discussions with the FDA remain ongoing regarding the appropriate path forward for sotrovimab in the US."
Those who purchased shares of GSK plc (NYSE: GSK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of GSK plc (NYSE: GSK) over possible Violations of Securities Laws here
News-ID: 2726242 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for GSK
GSK plc (NYSE: GSK) Investor Alert: Deadline in Lawsuit on April 7, 2025
A deadline is coming up on April 7, 2025 in the lawsuit filed for certain investors of GSK plc (NYSE: GSK) over alleged securities laws violations by GSK plc.
Investors who purchased shares of GSK plc (NYSE: GSK) have certain options and there are strict and short deadlines running. Deadline: April 7, 2025. GSK plc (NYSE: GSK) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According…
Lawsuit filed for Investors in shares of GSK plc (NYSE: GSK) over alleged Securi …
An investor, who purchased shares of GSK plc (NYSE: GSK), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by GSK plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of GSK plc (NYSE: GSK) have certain options and for certain investors are short and strict deadlines running. Deadline: April 7, 2025. NYSE: GSK investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Zoster Vaccine Live Market | GSK, Merck, ,
The global zoster vaccine live market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the zoster vaccine live market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Investigation announced for Investors in GSK plc (NYSE: GSK) over potential Wron …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at GSK plc.
Investors who purchased shares of GSK plc (NYSE: GSK) and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain GSK directors breached their fiduciary duties and caused damage to the company and its shareholders.
United Kingdom based GSK plc, together with its…
Vaccines Industry Market Growth Prospects And Outlook 2022-2027| GSK, Sanofi, Me …
The Vaccines market outlook looks extremely promising is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain, future roadmaps and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.
Top Companies in the Global…
2019-2024 | Vaccines Market Top Business Players: Vaccines Market GSK, Sanofi, …
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily…
